Terazosin And Metabolic Energetics in Parkinson's Disease

ClinicalTrials.gov ID: NCT07464028

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07464028. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 14, 2026, 6:49 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Assessing Target Engagement for Terazosin in Parkinson's Disease (TZPD2)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study investigates if Terazosin can improve metabolism in PD.

Study identification

NCT ID: NCT07464028
Recruitment status: Suspended
Study type: Interventional
Phase: Phase 2
Lead sponsor: Ergun Y. Uc; Other
Enrollment: 120 participants

Conditions and interventions

Conditions

Parkinson's Disease (PD)

Interventions

Terazosin 5 MG Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 50 Years to 80 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 1, 2028 (Estimated)
Primary completion: Jul 1, 2030 (Estimated)
Completion: Jul 1, 2031 (Estimated)
Last update posted: Oct 9, 2026

2028 – 2031

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
University of Iowa	Iowa City	Iowa	52242	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07464028, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 9, 2026 · Synced Nov 14, 2026